Literature DB >> 21712350

Leukocyte subsets dynamics following open pulmonary lobectomy for lung cancer: a prospective, observational study.

Mario Nosotti1, Lorenzo Rosso, Paolo Mendogni, Alessandro Palleschi, Davide Tosi, Paola Bonara, Luigi Santambrogio.   

Abstract

This study was planned to observe prospectively the effects of standard open pulmonary lobectomy on leukocyte subsets and their connection with oncological outcome. Leukocyte subsets from 200 patients undergoing pulmonary lobectomy were analyzed: 151 patients had non-small-cell lung cancer, and 49 had non-malignant diseases. Blood samples were taken for leukocyte flow cytometry before and five, 30 and 60 days after operation. The end points were: observation of postoperative leukocyte subsets that are dynamic in patients with lung cancer vs. patients without malignant disease; correlations between leukocyte subsets trend and disease-free interval or survival; and identification of prognostic factors related to preoperative leukocyte subsets. Lymphocyte counts significantly decreased at five days after lobectomy while monocyte counts increased, and complete recovery of the preoperative leukocyte setting was documented at 30 and 60 days. The patients with lung cancer showed a significant low percentage of human leukocyte antigens on their monocytes before surgery (P=0.0017), followed by a peculiar disarrangement of leukocytes subsets compared with patients without malignant disease at the five-day control point. There was no correlation between leukocyte subset dynamics and disease free interval or survival. This study proves reductions of T-, B and natural killer cells, and the expression of DR on T-lymphocyte after pulmonary lobectomy; oncological patients were significantly less affected by surgery than non-cancer patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21712350     DOI: 10.1510/icvts.2011.270512

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  3 in total

1.  MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteins.

Authors:  Julia Alles; Nicole Ludwig; Stefanie Rheinheimer; Petra Leidinger; Friedrich A Grässer; Andreas Keller; Eckart Meese
Journal:  Oncotarget       Date:  2017-05-07

2.  Peripheral lymphocyte populations in ovarian cancer patients and correlations with clinicopathological features.

Authors:  Shuang Ye; Wei Chen; Yuwei Zheng; Yutuan Wu; Libing Xiang; Teng Li; Bo Ping; Xiaoming Zhang; Huijuan Yang
Journal:  J Ovarian Res       Date:  2022-04-11       Impact factor: 4.234

Review 3.  Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes.

Authors:  Juan P Cata; Claudius Conrad; Katy Rezvani
Journal:  Scientifica (Cairo)       Date:  2015-10-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.